BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xiao J, Xu X, Li X, Li Y, Liu G, Tan H, Shen H, Shi H, Cheng D. Re-188 Enhances the Inhibitory Effect of Bevacizumab in Non-Small-Cell Lung Cancer. Molecules 2016;21:E1308. [PMID: 27706035 DOI: 10.3390/molecules21101308] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Gautam SK, Dalal V, Jain M, Batra SK. Delivery of radioimmunotherapy for solid tumors. Systemic Drug Delivery Strategies 2022. [DOI: 10.1016/b978-0-323-85781-9.00016-6] [Reference Citation Analysis]
2 Lepareur N, Lacœuille F, Bouvry C, Hindré F, Garcion E, Chérel M, Noiret N, Garin E, Knapp FFR Jr. Rhenium-188 Labeled Radiopharmaceuticals: Current Clinical Applications in Oncology and Promising Perspectives. Front Med (Lausanne) 2019;6:132. [PMID: 31259173 DOI: 10.3389/fmed.2019.00132] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 18.3] [Reference Citation Analysis]
3 Yudistiro R, Hanaoka H, Katsumata N, Yamaguchi A, Tsushima Y. Bevacizumab Radioimmunotherapy (RIT) with Accelerated Blood Clearance Using the Avidin Chase. Mol Pharm 2018;15:2165-73. [PMID: 29733658 DOI: 10.1021/acs.molpharmaceut.8b00027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
4 Shah SQ, Mahmood S. Evaluation of 99m Tc-Labeled Bevacizumab– N- HYNIC Conjugate in Human Ovarian Tumor Xenografts. Cancer Biotherapy and Radiopharmaceuticals 2018;33:96-102. [DOI: 10.1089/cbr.2017.2323] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Li H, Ha HL, Ding X, Bae C, Gazy N, Hao J, Zhong L. DMH4, a VEGFR2 inhibitor, effectively suppresses growth and invasion of lung cancer cells. J Appl Biomed 2018;16:46-50. [DOI: 10.1016/j.jab.2017.10.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 Uccelli L, Martini P, Pasquali M, Boschi A. Monoclonal Antibodies Radiolabeling with Rhenium-188 for Radioimmunotherapy. Biomed Res Int 2017;2017:5923609. [PMID: 28951872 DOI: 10.1155/2017/5923609] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
7 Xu P, Li H. [Application of Bevacizumab in Non-small Cell Lung Cancer]. Zhongguo Fei Ai Za Zhi 2017;20:272-7. [PMID: 28442017 DOI: 10.3779/j.issn.1009-3419.2017.04.08] [Reference Citation Analysis]